Comparison

SARCULATOR vs iCyst

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

SARCULATOR

This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.

Highlights
  • Predictive models for sarcoma patients
  • Estimates 5-year overall survival
  • Estimates 5-year disease-free survival
  • Estimates 10-year overall survival
  • Estimates cumulative incidence of distant metastasis
  • Informative tool for physicians
Features
Read full description

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

About

iCyst

Access and navigate up-to-date guidelines for managing pancreatic cystic neoplasms from European, IAP, and AGA sources. Input cyst features to receive management recommendations based on built-in algorithms. Save data anonymously for future reference.

Highlights
  • Access European, IAP, and AGA guidelines
  • Navigate guidelines in PDF and flowchart format
  • Input cyst features for recommendations
  • Built-in algorithm for management suggestions
  • Anonymous data saving and modification
  • Improve clinical practice for pancreatic cysts
Features
Read full description

COMPLETE THE SURVEY ON PANCREATIC CYSTIC NEOPLASMS (https://pancreasverona-ebm.bluemilk.cloud/guidelines-on-pancreatic-cystic-tumours), GET THE REGISTRATION CODE AND UNLOCK ALL FEATURES OF THE APP. iCyst – Improving Clinical Practice for Pancreatic Cystic Neoplasms, give direct access to up-to-date European, International Association of Pancreatology (IAP) and American Gastroenterological Association (AGA) guidelines for the management of pancreatic cystic neoplasms. You can quickly navigate through guidelines and flowchart. Insert all cyst’s features to get recommendations from the three different guidelines thanks to a built-in algorithm (feature available only after completing the survey in the above link). The app contains the following guidelines: European evidence-based guidelines on pancreatic cystic neoplasm (2018) Revision of the International Association of Pancreatology (2017 update) American Gastroenterological Association guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cyst (2015) The user can navigate the guidelines both in PDF and flowchart format. With iCyst the user can select cyst’s characteristic to assess the standard of treatment according to each guideline and select which of the guideline will be followed. Data can be saved anonymously and stored to be checked again or modified. Get updated, disseminate guidelines for the management pancreatic cysts and improve your clinical practice!

Screenshots

SARCULATOR4 screens
iCyst4 screens

Verdict

The call

The clearest difference is update cadence: iCyst at weekly against SARCULATOR's every 6 months. iCyst also leads on iOS requirement (11.4 vs 15.0). On price, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

SARCULATOR ships an update every 6 months, iCyst weekly. The most recent releases landed on October 24, 2026 and September 24, 2026 respectively.

Scorecard2 real differences · 8 level
SARCULATOR versus iCyst: the parameters behind the verdict, then further details
ParameterSARCULATORiCyst
PriceFreeFree
Rating4.3 (3 ratings) — better—
Positive reviews—100.0% of reviews
Number of ratings3 — better—
Update frequencyEvery 6 monthsWeekly — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS15.011.4 — better
Further details — not scored
Size29 MB28 MB
Age rating12+17+
DeveloperDIGITAL FOREST SRLBlue Milk Srl

Customer experience

SARCULATOR

All ratings3 ratings
Positive66.7%
Neutral33.3%
Negative0.0%

iCyst

Written reviews6 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

SARCULATOR

No in-app purchases

None

iCyst

No in-app purchases

Questions

Is SARCULATOR free?
SARCULATOR is free to download, with no in-app purchases.
Is iCyst free?
iCyst is free to download, with no in-app purchases.
Do SARCULATOR or iCyst have ads?
Neither SARCULATOR nor iCyst shows ads.
Which is updated more often, SARCULATOR or iCyst?
SARCULATOR ships an update every 6 months, and iCyst weekly. Most recently, SARCULATOR was updated on October 24, 2026 and iCyst on September 24, 2026.

Other comparisons